Anifrolumab: Solution concentrate for I.V. infusion 300 mg in 2 mL vial; Saphnelo® Page last updated: 30 June 2023 Public Summary Document (PSD) March 2023 PBAC Meeting - (PDF 1.3MB) Public Summary Document (PSD) March 2023 PBAC Meeting - (Word 529KB)